NEUP
Price
$16.05
Change
-$0.67 (-4.01%)
Updated
Oct 14 closing price
Capitalization
37.58M
Intraday Buy/Sell Signals
QLGN
Price
$3.81
Change
-$0.20 (-4.99%)
Updated
Oct 14 closing price
Capitalization
7.86M
Intraday Buy/Sell Signals
Interact to see
Advertisement

NEUP vs QLGN

Header iconNEUP vs QLGN Comparison
Open Charts NEUP vs QLGNBanner chart's image
Neuphoria Therapeutics
Price$16.05
Change-$0.67 (-4.01%)
Volume$132.85K
Capitalization37.58M
Qualigen Therapeutics
Price$3.81
Change-$0.20 (-4.99%)
Volume$126.48K
Capitalization7.86M
NEUP vs QLGN Comparison Chart in %
NEUP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QLGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NEUP vs. QLGN commentary
Oct 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEUP is a Hold and QLGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 15, 2025
Stock price -- (NEUP: $16.05 vs. QLGN: $3.81)
Brand notoriety: NEUP and QLGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NEUP: 164% vs. QLGN: 6%
Market capitalization -- NEUP: $37.58M vs. QLGN: $7.86M
NEUP [@Biotechnology] is valued at $37.58M. QLGN’s [@Biotechnology] market capitalization is $7.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $105.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NEUP’s FA Score shows that 2 FA rating(s) are green whileQLGN’s FA Score has 2 green FA rating(s).

  • NEUP’s FA Score: 2 green, 3 red.
  • QLGN’s FA Score: 2 green, 3 red.
According to our system of comparison, NEUP is a better buy in the long-term than QLGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NEUP’s TA Score shows that 3 TA indicator(s) are bullish while QLGN’s TA Score has 5 bullish TA indicator(s).

  • NEUP’s TA Score: 3 bullish, 4 bearish.
  • QLGN’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, QLGN is a better buy in the short-term than NEUP.

Price Growth

NEUP (@Biotechnology) experienced а -14.49% price change this week, while QLGN (@Biotechnology) price change was -24.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.76%. For the same industry, the average monthly price growth was +13.99%, and the average quarterly price growth was +268.92%.

Industries' Descriptions

@Biotechnology (+0.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NEUP($37.6M) has a higher market cap than QLGN($7.86M). NEUP has higher P/E ratio than QLGN: NEUP (0.78) vs QLGN (0.61). NEUP YTD gains are higher at: 367.930 vs. QLGN (-9.501). NEUP has higher annual earnings (EBITDA): 192K vs. QLGN (-6.28M). NEUP has more cash in the bank: 17M vs. QLGN (332K). NEUP has less debt than QLGN: NEUP (172K) vs QLGN (3.62M). NEUP has higher revenues than QLGN: NEUP (15.7M) vs QLGN (0).
NEUPQLGNNEUP / QLGN
Capitalization37.6M7.86M478%
EBITDA192K-6.28M-3%
Gain YTD367.930-9.501-3,872%
P/E Ratio0.780.61127%
Revenue15.7M0-
Total Cash17M332K5,120%
Total Debt172K3.62M5%
FUNDAMENTALS RATINGS
QLGN: Fundamental Ratings
QLGN
OUTLOOK RATING
1..100
36
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NEUPQLGN
RSI
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 8 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 8 days ago
83%
Momentum
ODDS (%)
Bullish Trend 8 days ago
83%
Bullish Trend 8 days ago
82%
MACD
ODDS (%)
Bullish Trend 8 days ago
90%
Bearish Trend 8 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 8 days ago
86%
Bearish Trend 8 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 8 days ago
85%
Bullish Trend 8 days ago
78%
Advances
ODDS (%)
Bullish Trend 10 days ago
90%
Bullish Trend 15 days ago
83%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 8 days ago
85%
Aroon
ODDS (%)
N/A
Bullish Trend 8 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
NEUP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QLGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NPB17.590.57
+3.35%
Northpointe Bancshares Inc
MNDR3.610.09
+2.56%
Mobile-health Network Solutions
ACMR38.11-0.51
-1.33%
ACM Research
TEM89.87-4.60
-4.87%
Tempus AI Inc.
ZNTL1.54-0.08
-4.94%
Zentalis Pharmaceuticals

NEUP and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEUP has been loosely correlated with QLGN. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if NEUP jumps, then QLGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEUP
1D Price
Change %
NEUP100%
-4.01%
QLGN - NEUP
61%
Loosely correlated
-4.99%
SLGL - NEUP
40%
Loosely correlated
-0.50%
CMND - NEUP
32%
Poorly correlated
-0.27%
MNPR - NEUP
25%
Poorly correlated
-6.62%
PPBT - NEUP
25%
Poorly correlated
-2.12%
More

QLGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, QLGN has been loosely correlated with NEUP. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if QLGN jumps, then NEUP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QLGN
1D Price
Change %
QLGN100%
-4.99%
NEUP - QLGN
61%
Loosely correlated
-4.01%
MBX - QLGN
37%
Loosely correlated
-6.76%
NEVPF - QLGN
35%
Loosely correlated
N/A
ZLDAF - QLGN
34%
Loosely correlated
N/A
NTLA - QLGN
33%
Loosely correlated
+0.59%
More